Endo Fha Fertility Gonadotropin Therapy Cautious

---
name: endo-fha-fertility-gonadotropin-therapy-cautious
description: This skill advises exercising caution when using gonadotropin therapy (FSH/LH) for ovulation induction in patients with functional hypothalamic amenorrhea (FHA), particularly monitoring for ovarian hyperresponse and multiple gestations. It is triggered when a clinician states, “We’ll use gonadotropins but watch for overstimulation,” or phrases such as “Use gonadotropins cautiously” or “Monitor estradiol and follicle count during gonadotropin therapy”.
---

# Cautious use of gonadotropin therapy for ovulation induction in FHA

## STEP 1 — Gather Information
Collect confirmation of FHA diagnosis (exclusion of organic causes), baseline estradiol, antral follicle count (AFC), BMI, and ensure patient desires conception after complete fertility workup.
→ Proceed to assess eligibility for gonadotropin therapy.

## STEP 2 — Rule In / Rule Out
Rule out pregnancy and confirm BMI ≥18.5 kg/m²; if either is not met, do not proceed with gonadotropin therapy.
→ If pregnancy excluded and BMI ≥18.5 kg/m², proceed to stratify ovarian response risk.

## STEP 3 — Classify or Stratify
Stratify risk: low risk if baseline estradiol <50 pg/mL and AFC <5; high risk if estradiol ≥50 pg/mL or AFC ≥5.
→ If low risk, initiate low‑dose gonadotropin; if high risk, use extreme caution or consider alternative ovulation induction.

## STEP 4 — Decide
For low risk, start gonadotropin at 37.5 IU FSH daily, monitor estradiol and follicle count every 2–3 days; cancel if ≥3 follicles ≥14 mm or estradiol rises >2000 pg/mL or rapid increase. For high risk, consider ultra‑low dose (≤15 IU daily) or GnRH if available, with same monitoring.
→ Continue monitoring until ovulation trigger (hCG when ≥2 follicles ≥16 mm) or cycle cancellation.

## Clinical Guardrails / Mimics / Pitfalls
Do not exceed dose increments of 12.5–25 IU per step; avoid triggering with estradiol >4000 pg/mL; counsel patients on ≥20% risk of multiples with gonadotropins; do not use in BMI <18.5 kg/m²; monitor for ovarian hyperstimulation syndrome (OHSS) and cancel if symptoms develop.

## Concrete Clinical Example
A 28‑year‑old woman with FHA (BMI 20, estradiol 30 pg/mL, AFC 3) desires pregnancy. After pregnancy exclusion and FHA confirmation, low‑risk stratification leads to gonadotropin 37.5 IU daily. Monitoring shows two follicles ≥16 mm and estradiol 800 pg/mL on day 8; hCG trigger is given, resulting in a singleton pregnancy.

**Source:** Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2017, DOI:10.1210/jc.2017-00131